Owner YAMANOUCHI PHARMACEUTICAL CO., LTD.

Inventors OKADA, Minoru; FURUTANI, Takashi; TANIGUCHI, Nobuaki; IMAMURA, Masakazu; HAYAKAWA, Masahiko; KAWAGUCHI, Kenichi; KIMURA, Takenori; KINOYAMA, Isao; KAIZAWA, Hiroyuki

Pub. Number AU-A-2003248052

PCT Number PCT/JP03/08860

PCT Pub. Number WO2004/007471

Priority 2002-203690 12.07.02 JP

Filing date 11 July 2003

Wipo publication date 2 February 2004

C07D 241/04 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 031/498 - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 031/506 - not condensed and containing further heterocyclic rings

A61K 031/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 031/5377

A61P 005/28 Drugs for disorders of the endocrine system

A61P 013/08 Drugs for disorders of the urinary system

A61P 017/08 Drugs for dermatological disorders

A61P 017/14 Drugs for dermatological disorders

A61P 035/00 Antineoplastic agents

C07D 213/75 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/85 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members